tiprankstipranks
Trending News
More News >
Galecto, Inc. (GLTO)
:GLTO
US Market
Advertisement

Galecto (GLTO) Price & Analysis

Compare
222 Followers

GLTO Stock Chart & Stats


Galecto News

GLTO FAQ

What was Galecto, Inc.’s price range in the past 12 months?
Galecto, Inc. lowest stock price was $2.01 and its highest was $14.82 in the past 12 months.
    What is Galecto, Inc.’s market cap?
    Galecto, Inc.’s market cap is $3.99M.
      When is Galecto, Inc.’s upcoming earnings report date?
      Galecto, Inc.’s upcoming earnings report date is Oct 31, 2025 which is in 52 days.
        How were Galecto, Inc.’s earnings last quarter?
        Galecto, Inc. released its earnings results on Aug 05, 2025. The company reported -$2.6 earnings per share for the quarter, missing the consensus estimate of N/A by -$2.6.
          Is Galecto, Inc. overvalued?
          According to Wall Street analysts Galecto, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Galecto, Inc. pay dividends?
            Galecto, Inc. does not currently pay dividends.
            What is Galecto, Inc.’s EPS estimate?
            Galecto, Inc.’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Galecto, Inc. have?
            Galecto, Inc. has 1,324,560 shares outstanding.
              What happened to Galecto, Inc.’s price movement after its last earnings report?
              Galecto, Inc. reported an EPS of -$2.6 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Galecto, Inc.?
                Currently, no hedge funds are holding shares in GLTO

                Company Description

                Galecto, Inc.

                Galecto, Inc. (GLTO) is a biotechnology company focused on the development of novel therapeutics for the treatment of fibrotic diseases, cancer, and other related conditions. The company is primarily engaged in the research and development of small molecule inhibitors that target galectin proteins, which are involved in various biological processes. Galecto's lead product candidates are designed to address unmet medical needs in fibrotic and inflammatory diseases, offering innovative solutions aimed at improving patient outcomes.

                Galecto (GLTO) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Matinas BioPharma
                Quoin Pharmaceuticals
                Silo Pharma
                GRI Bio
                Conduit Pharmaceuticals

                Ownership Overview

                2.65%1.61%7.54%87.75%
                7.54% Other Institutional Investors
                87.75% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis